Tryptamine has kicked off its world-first Binge Eating Disorder trial with psilocin, with dosing around the corner and potential to ... Read More The post Tryptamine opens patient recruitment for ...

Tryptamine Therapeutics Limited has successfully completed multiple offers, raising a total of $6.5 million and issuing over 1.5 billion shares and options post the acquisition of Tryp ...

This new patent, issued July 25, 2023, provides Enveric with intellectual property rights for compositions and methods for tryptamine-derived prodrugs utilizing C 4 -substituted tryptamine ...

This patent complements the recently issued U.S. patent (11,707,447), titled “C4-Carbonothioate-substituted Tryptamine Derivatives and Methods of Using,” providing Enveric with a robust ...